Fig. 1 (Structural Formula of Prandin)
Prandin
Product Images NDC 68151-3565
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Prandin (NDC 68151-3565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Carilion Materials Management, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Fig. 2 (Prandin Pioglitazone Combination Study)
Label Image (Lbl681513565)
Prandin is a prescription medication containing repaglinide, which is used to treat high blood sugar in people with type 2 diabetes. It is manufactured by Novo Nordisk and the specific container lot number is A108739. The medication comes in the form of a 0.5 mg tablet and the expiration date is 08/14. The rest of the text is not readable.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
